JP9-16689-35871
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 662 / KS
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
-
2021-01-18
Survey response — day 14, dose 1MedDRA: Heart rate increased, Tachycardia — Feeling: GoodFree text: Sustained tachycardia in 120s about 18 hrs after vaccine. Down to 80s 30 hrs after vaccine. Now with resting heart rate in 70s, goes up to 90s with minimal exertion (standing up). Prior to vaccine RHR was in low 60s.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Dose 2 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-10
- 2021-07-26
-
2021-09-20
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech | |
| 3 | 2021-09-20 | Pfizer-BioNTech | No |
Free text
Release 2 — day 14, dose 1
Symptoms: Sustained tachycardia in 120s about 18 hrs after vaccine. Down to 80s 30 hrs after vaccine. Now with resting heart rate in 70s, goes up to 90s with minimal exertion (standing up). Prior to vaccine RHR was in low 60s.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release